2023 annual financial data

Ovid Therapeutics 2023 Net margin

Direct answer

Net margin was -13,351.79%.

Operating income was -59.28M USD and net income was -52.34M USD.
Operating cash flow was -45.78M USD.

Get free Ovid Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
392,000 USD
Operating income
-59.28M USD
Net income
-52.34M USD
Operating cash flow
-45.78M USD